CORLUXIN, created in 2011 (United States), from
2 sister brands
and 2214 competing brands.
The CORLUXIN brand is owned by Corcept Therapeutics, a company listed in New York.
CORLUXIN belongs to the Biotechnology business sector.
CORLUXIN is a brand of Corcept Therapeutics (CORT) News
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.